» Articles » PMID: 33502062

Initiating Hybrid Closed Loop: A Program Evaluation of an Educator-led Control-IQ Follow-up at a Large Pediatric Clinic

Overview
Publisher Wiley
Date 2021 Jan 27
PMID 33502062
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Control-IQ (Tandem Diabetes) is a hybrid closed-loop (HCL) system that users self-initiate after completing online training. Best practices for clinical follow-up are not known. Our quality improvement objective was to evaluate the usefulness of an educator-led follow-up program for new HCL users in a type 1 diabetes pediatric clinic.

Methods: We implemented an ''HCLCheck-in'' program, first determining when users started HCL, then having diabetes educators contact them for a follow-up call 2-weeks after start. Educators used a Clinical Tool to inform insulin dose and behavior recommendations, and used four benchmarks to determine need for further follow-up: ≥71% HCL use, ≥71% CGM use, ≥60% Time-in-Range (TIR, 70-180 mg/dL), <5% below 70 mg/dL. Family and educator satisfaction were surveyed.

Results: One-hundred-twenty-three youth [mean age 13.6 ± 3.7 y, 53.7% female, mean HbA1c 7.6 ± 1.4% (60 mmol/mol)] completed an HCLCheck-in call a median (IQR) of 18(15, 21) days post-HCL start. 74 users (60%) surpassed benchmarks with 94% HCL use and 71% TIR. Of the 49 who did not, 16 completed a second call, and improved median TIR 12.5% (p = 0.03). HCL users reported high satisfaction with the program overall [median 10 (9, 10) out of 10]. Educators spent a median of 45 (32,70) minutes per user and rated satisfaction with the program as 8 (7,9.5) and the Tool as 9 (9, 10).

Conclusion: Our HCLCheck-in program received high satisfaction ratings and resulted in improved TIR for those initially not meeting benchmarks, suggesting users may benefit from early follow-up. Similar programs may be beneficial for other new technologies.

Citing Articles

International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Diabetes Technologies - Insulin Delivery.

Biester T, Berget C, Boughton C, Cudizio L, Ekhlaspour L, Hilliard M Horm Res Paediatr. 2024; 97(6):636-662.

PMID: 39657603 PMC: 11854989. DOI: 10.1159/000543034.


Increasing Use of Diabetes Devices: What Do Health Care Professionals Need?.

Messer L, Vigers T, Akturk H, Forlenza G, Huss K, Karami A Clin Diabetes. 2023; 41(3):386-398.

PMID: 37456091 PMC: 10338282. DOI: 10.2337/cd22-0092.


Barriers and Facilitators to Diabetes Device Adoption for People with Type 1 Diabetes.

Tanenbaum M, Commissariat P Curr Diab Rep. 2022; 22(7):291-299.

PMID: 35522355 PMC: 9189072. DOI: 10.1007/s11892-022-01469-w.


Trends in Glycemic Control Among Youth and Young Adults With Diabetes: The SEARCH for Diabetes in Youth Study.

Malik F, Sauder K, Isom S, Reboussin B, Dabelea D, Lawrence J Diabetes Care. 2022; 45(2):285-294.

PMID: 34995346 PMC: 8914430. DOI: 10.2337/dc21-0507.


Real-World Use of a New Hybrid Closed Loop Improves Glycemic Control in Youth with Type 1 Diabetes.

Messer L, Berget C, Pyle L, Vigers T, Cobry E, Driscoll K Diabetes Technol Ther. 2021; 23(12):837-843.

PMID: 34096789 PMC: 8819505. DOI: 10.1089/dia.2021.0165.


References
1.
Berget C, Messer L, Forlenza G . A Clinical Overview of Insulin Pump Therapy for the Management of Diabetes: Past, Present, and Future of Intensive Therapy. Diabetes Spectr. 2019; 32(3):194-204. PMC: 6695255. DOI: 10.2337/ds18-0091. View

2.
Forlenza G, Cameron F, Ly T, Lam D, Howsmon D, Baysal N . Fully Closed-Loop Multiple Model Probabilistic Predictive Controller Artificial Pancreas Performance in Adolescents and Adults in a Supervised Hotel Setting. Diabetes Technol Ther. 2018; 20(5):335-343. PMC: 5963546. DOI: 10.1089/dia.2017.0424. View

3.
Kovatchev B, Patek S, Dassau E, Doyle 3rd F, Magni L, De Nicolao G . Control to range for diabetes: functionality and modular architecture. J Diabetes Sci Technol. 2010; 3(5):1058-65. PMC: 2769910. DOI: 10.1177/193229680900300509. View

4.
Clarke W, Anderson S, Breton M, Patek S, Kashmer L, Kovatchev B . Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience. J Diabetes Sci Technol. 2010; 3(5):1031-8. PMC: 2769907. DOI: 10.1177/193229680900300506. View

5.
Messer L, Berget C, Vigers T, Pyle L, Geno C, Wadwa R . Real world hybrid closed-loop discontinuation: Predictors and perceptions of youth discontinuing the 670G system in the first 6 months. Pediatr Diabetes. 2019; 21(2):319-327. PMC: 7204392. DOI: 10.1111/pedi.12971. View